2011 Publications

Avirutnan P, Hauhart RE, Marovich MA, Garred P, Atkinson JP, Diamond MS. Complement-mediated neutralization of dengue virus requires mannose-binding lectin. MBio. 2011 Dec 13;2(6). pii: e00276-11. doi: 10.1128/mBio.00276-11. Print 2011. PubMed PMID: 22167226; PubMed Central PMCID: PMC3236064.

Currier JR, Robb ML, Michael NL, Marovich MA. Defining epitope coverage requirements for T cell-based HIV vaccines: Theoretical considerations and practical applications. J Transl Med. 2011 Dec 8;9(1):212. [Epub ahead of print] PubMed PMID: 22152192.

Michael NL. Rare serotype adenoviral vectors for HIV vaccine development. J Clin Invest. 2011 Dec 27:1-3. doi: 10.1172/JCI60988. [Epub ahead of print] PMID: 22201675.

Peachman KK, Li Q, Matyas GR, Shivachandra SB, Lovchik J, Lyons RC, Alving CR, Rao VB, Rao M. Anthrax Vaccine Antigen-Adjuvant Formulations Completely Protect New Zealand White Rabbits against Challenge with Bacillus anthracis Ames Strain Spores. Clin Vaccine Immunol. 2011 Nov 16. [Epub ahead of print] PubMed PMID: 22089245.

Alving CR, Rao M, Peachman KK, Asher L, Rao VB. Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation. J Liposome Res. 2011 Dec;21(4):279-85. Epub 2011 Mar 14. PubMed PMID: 21401373.
Eller MA, Slike BM, Cox JH, Lesho E, Wang Z, Currier JR, Darden JM, PolonisVR, Vahey MT, Peel S, Robb ML, Michael NL, Marovich MA. A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.PLoS One. 2011;6(9):e24254. Epub 2011 Sep 16. PubMed PMID: 21949699.

Matyas GR, Alving CR. Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine Containing lipid A. Vaccine. 2011 Jul 18; 29(32): 5137-44. Epub  2011 May 30. PubMed PMID: 21624414.

Eller MA, Blom KG, Gonzalez VD, Eller LA, Naluyima P, Laeyendecker O, Quinn TC, Kiwanuka N, Serwadda D, Sewankambo NK, Tasseneetrithep B, Wawer MJ, Gray RH, Marovich MA, Michael NL, de Souza MS, Wabwire-Mangen F, Robb ML, Currier JR, Sandberg JK. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans. PLoS One. 2011 Apr 19; 6(4): e18779. PubMed PMID: 21526194.

Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S,Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG,  Pau MG, Goudsmit J. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 2011 Jul 18;29(32):5203-9. Epub 2011 May 25.

Alving CR, Rao M, Peachman KK, Asher L, Rao VB. Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation. J Liposome Res. 2011 Mar 14. [Epub ahead of print].

Beck Z, Brown BK, Matyas GR, Polonis VR, Rao M, Alving CR. Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: Effects of antibodies and complement. Virology. 2011 Apr 10;412(2):441-7.

Rao M, Peachman KK, Li Q, Matyas GR, Shivachandra SB, Borschel R, Morthole VI, Fernandez-Prada C, Alving CR, Rao VB. Highly effective generic adjuvant systems for orphan or poverty-related vaccines. Vaccine. 2011 Jan 29;29(5):873-7.

Steers NJ, Currier JR, Kijak GH, di Targiani RC, Saxena A, Marovich MA, Kim JH, Michael NL, Alving CR, Rao M. Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire. J Virol. 2011 Feb;85(4):1541-53.

Eller MA, Koehler RN, Kijak GH, Eller LA, Guwatudde D, Marovich MA, Michael NL, de Souza MS, Wabwire-Mangen F, Robb ML, Currier JR, Sandberg JK. Human Immunodeficiency Virus Type 1 Infection is Associated with Increased NK Cell Polyfunctionality and Higher Levels of KIR3DL1+ NK Cells in Ugandans Carrying the HLA-B Bw4 Motif. J Virol. 2011 Mar 16.

Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol. 2011 Feb;85(4):1671-83.

Manak M, Sina S, Anekella B, Hewlett I, Sanders-Buell EE, Ragupathy V, Kim JH, Vermeulen M, Stramer S, Sabino E, Grabarczyk P, Michael NL, Peel S, Garrett PE, Tovanabutra S, Busch M, Schito M. Pilot Studies for Development of an HIV Subtype Panel for Surveillance of Global Diversity. AIDS Res Hum Retroviruses. 2011 Dec 9. [Epub ahead of print] PubMed PMID: 22149143.

Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, Benenson M, Morgan P, O'Connell RJ, Berenberg J, Gurunathan S, Francis DP, Paris R, Chiu J, Stablein D, Michael NL, Excler JL, Robb ML, Kim JH. Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand. PLoS One. 2011;6(12):e27837. Epub 2011 Dec 21. PMID: 22205930.

Zollinger WD, Babcock JG, Moran EE, Brandt BL, Matyas GR, Wassef NM, Alving CR. Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide. Vaccine. 2011 Dec 1. [Epub ahead of print] PubMed PMID: 22138211.

McLinden RJ, Paris RM, Polonis VR, Close NC, Su Z, Shikuma CM, Margolis DM, Kim JH. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (a5170). AIDS. 2011 Oct 3. [Epub ahead of print] PubMed PMID: 21971356.

Bakari M, Aboud S, Nilsson C, Francis J, Buma D, Moshiro C, Aris EA, Lyamuya EF, Janabi M, Godoy-Ramirez K, Joachim A, Polonis VR, Brave A, Earl P, Robb M, Marovich M, Wahren B, Pallangyo K, Biberfeld G, Mhalu F, Sandström E. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine. 2011 Oct 26;29(46):8417-28. Epub 2011 Aug 22.
Robb M. HIV vaccine development: a new beginning. Expert Rev Vaccines. 2011 Jul;10(7):925-7. PubMed PMID: 21806389.

Robb M. Set up the right connections. Health Serv J. 2011 Mar 3;121(6246):24-5. PubMed PMID: 21604628.Chen RT, Hu DJ, Dunne E, Shaw M, Mullins J, Rerks-Ngarm S. Preparing for the availability of a partially effective HIV vaccine: Some lessons from other licensed vaccines. Vaccine. 2011 Aug 18;29(36):6072-8. Epub 2011 Jul 13. PubMed PMID: 21745523.

Malia, J. Clinical Laboratory training in developing countries: An introduction for the U. S. Public Health Services. U.S. Public Health Newsletter 2011.
Kijak GH, Beyrer C, Tovanabutra S, Sripaipan T, Suriyanon V, Moqueet N, Sanders-Buell E, Saokhieo P, Timpan U, Jittiwutikarn J, Robb ML, Birx DL, Celentano DD, McCutchan FE. Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: Associations of risk with genetic complexity. Drug Alcohol Depend. 2011 Jul 1;116(1-3):24-30. Epub 2010 Dec 28.

Oballah P, Flach B, Eller LA, Eller MA, Ouma B, de Souza M, Kibuuka HN, Wabwire-Mangen F, Brown BK, Michael NL, Robb ML, Montefiori D, Polonis VR. B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses. PLoS One. 2011;6(8):e22653.

Rolland M, Tovanabutra S, Decamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, O'Sullivan A, Crossler J, Jones T, Nau  M, Wong K, Zhao H, Raugi DN, Sorensen S, Stoddard JN, Maust BS, Deng W, Hural J,  Dubey S, Michael NL, Shiver J, Corey L, Li F, Self SG, Kim J, Buchbinder S, Casimiro DR, Robertson MN, Duerr A, McElrath MJ, McCutchan FE, Mullins JI. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med. 2011 Mar;17(3):366-71.

Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviors amongst injecting drug users in three Afghan cities. Int J Drug Policy. 2011 Mar;22(2):145-52. Epub 2010 Dec 10. PubMed PMID: 21146392.

Todd CS, Nasir A, Stanekzai MR, Scott PT, Close NC, Botros BA, Strathdee SA, Tjaden J. HIV awareness and condom use among female sex workers in Afghanistan: implications for intervention. AIDS Care. 2011 Mar;23(3):348-56.

Hakre S, Brett-Major DM, Singer D, O ºconnell RJ, Sateren WB, Sanchez JL, Agan BK, Michael NL, Scott PT. Medical Encounter Characteristics of HIV Seroconverters in the US Army and Air Force, 2000-2004. J Acquir Immune Defic Syndr. 2011 Jan 24.

Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Kim JH, Strathdee SA, Tjaden J. Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities. Int J Infect  Dis. 2011 Mar;15(3):e201-5.

Hakre S, Peel SA, O'Connell RJ, Sanders-Buell EE, Jagodzinski LL, Eggleston JC, Myles O, Waterman PE, McBride RH, Eader SA, Davis KW, Rentas FJ, Sateren WB, Naito NA, Tobler SK, Tovanabutra S, Petruccelli BP, McCutchan FE, Michael NL, Cersovsky SB, Scott PT. Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom. Transfusion. 2011 Mar;51(3):473-485.

Geis S, Maboko L, Saathoff E, Hoffmann O, Geldmacher C, Mmbando D, Samky E, Michael NL, Birx DL, Robb ML, Hoelscher M. Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania. J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):453-9. Epub 2011 Feb 4.

Todd CS, Stibich MA, Laher F, Malta MS, Bastos FI, Imbuki K, Shaffer DN, Sinei SK, Gray GE. Influence of culture on contraceptive utilization among HIV-positive women in Brazil, Kenya, and South Africa. AIDS Behav. 2011 Feb;15(2):454-68.